PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution

Leonie I Kroeze1, B Scheijen2,3, K M Hebeda2

  • 1Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, the Netherlands. leonie.kroeze@radboudumc.nl.

Insights

Next-generation sequencing (NGS) identified immunoglobulin (IG) gene rearrangements in a patient with B-cell acute lymphoblastic leukemia (B-ALL) and subsequent histiocytic sarcoma (HS). This analysis revealed clonal evolution, showing one B-ALL subclone developing into HS after acquiring a RAF1 mutation.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Clonality assessment using immunoglobulin (IG) gene rearrangements is crucial for distinguishing related lymphoid malignancies.
  • Understanding clonal evolution in sequential cancers aids in clinicobiological insights.

Purpose of the Study:

  • To detail the clonality analysis in a patient with sequential B-cell acute lymphoblastic leukemia (B-ALL) and histiocytic sarcoma (HS).
  • To investigate clonal evolution using next-generation sequencing (NGS) for IG rearrangements and gene mutations.

Main Methods:

  • Next-generation sequencing (NGS) was employed to detect IG gene rearrangements and identify gene mutations.
  • Clonality analysis was performed on samples from a patient with sequential B-ALL and HS.

Main Results:

  • NGS identified multiple related subclones within the PAX5 P80R-mutated B-ALL.
  • One specific subclone evolved into HS, acquiring a RAF1 mutation.
  • The study successfully tracked clonal evolution from B-ALL to HS.

Conclusions:

  • NGS-based IG clonality assessment and mutation analysis are valuable for comparing cancer clones.
  • This approach enhances clinicobiological understanding of sequential malignancies.
  • The findings highlight the utility of NGS in deciphering complex cancer evolution.